These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3958161)

  • 1. Humoral immune responses within the human central nervous system following systemic immunization.
    Sandberg-Wollheim M; Zweiman B; Levinson AI; Lisak RP
    J Neuroimmunol; 1986 May; 11(3):205-14. PubMed ID: 3958161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetanus toxoid reactive T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients.
    Burns J; Zweiman B; Lisak R
    Immunol Commun; 1984; 13(4):361-9. PubMed ID: 6237050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
    Geha RS
    J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin.
    Fagiolo U; Amadori A; Biselli R; Paganelli R; Nisini R; Cozzi E; Zamarchi R; D'Amelio R
    Vaccine; 1993 Oct; 11(13):1336-40. PubMed ID: 8296487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro humoral immune response of human peripheral blood lymphocytes to tetanus toxoid sepharose 4B.
    Khansari N; Fudenberg HH; Merler E
    Immunobiology; 1983 Feb; 164(1):42-50. PubMed ID: 6852857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing immune competence in pigs by immunization with tetanus toxoid.
    Gimsa U; Tuchscherer A; Gimsa J; Tuchscherer M
    Animal; 2018 Jan; 12(1):116-121. PubMed ID: 28554336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid lymphocytes from patients with multiple sclerosis do not increase immunoglobulin or measles antibody production after stimulation with pokeweed mitogen.
    Henriksson A; Kam-Hansen S; Forsberg P; Grandien M
    J Neuroimmunol; 1986 Mar; 11(1):15-30. PubMed ID: 3944248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
    Ershler WB; Moore AL; Hacker MP
    Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    Geha RS
    J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
    Kodo H; Gale RP; Saxon A
    J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses.
    Somani J; Lonial S; Rosenthal H; Resnick S; Kakhniashvili I; Waller EK
    Vaccine; 2002 Dec; 21(3-4):221-30. PubMed ID: 12450697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization.
    Livingston KA; Jiang X; Stephensen CB
    J Immunol Methods; 2013 Apr; 390(1-2):18-29. PubMed ID: 23318779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination.
    Burns EA; Lum LG; L'Hommedieu G; Goodwin JS
    J Gerontol; 1993 Nov; 48(6):B231-6. PubMed ID: 8227990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.
    Lum LG; Seigneuret MC; Storb R
    J Clin Immunol; 1986 Sep; 6(5):389-96. PubMed ID: 2429980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro IgM rheumatoid-factor production induced by tetanus toxoid.
    Levinson AI; Tar L
    J Allergy Clin Immunol; 1988 Apr; 81(4):730-6. PubMed ID: 3258604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide.
    Munoz JL; Insel RA
    J Immunol; 1987 Sep; 139(6):2026-31. PubMed ID: 3040862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary immunization with a protein antigen (tetanus toxoid) in man. Characterization of humoral and cell-mediated regulatory events.
    Donnenberg AD; Elfenbein GJ; Santos GW
    Scand J Immunol; 1984 Oct; 20(4):279-89. PubMed ID: 6209787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis.
    Roström B; Link H; Laurenzi MA; Kam-Hansen S; Norrby E; Wahren B
    Ann Neurol; 1981 Jun; 9(6):569-74. PubMed ID: 7259119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased specific antibody synthesis in old adults: decreased potency of antigen-specific B cells with aging.
    Burns EA; Lum LG; Seigneuret MC; Giddings BR; Goodwin JS
    Mech Ageing Dev; 1990 Apr; 53(3):229-41. PubMed ID: 2376983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.